AstraZeneca Q3 Profit Rises 23%; Headline Also Cites $1.5B Cuts and $2B Summit Stake
The headline cites a 23% increase in AstraZeneca’s third-quarter profit, $1.5 billion in cuts and a $2 billion Summit stake. The underlying details are not provided.